Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (61-70 of 239) with videos related to

Pageof 24
Sort By:
Cancer Research|January 30, 2019
The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3Giovanni Gambi, Elisabetta Di Simone, Veronica Basso, et al.
Blood|September 29, 2005
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomasRoberto Piva, Roberto Chiarle, Andrea D Manazza, et al.
Virchows Archiv : an International Journal of Pathology|July 10, 2003
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumoursMarco Chilosi, Alberto Zamò, Antonietta Brighenti, et al.
Anticancer Research|December 27, 2011
Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinomaDeepu Mirchandani, Daniel F Roses, Giorgio Inghirami, et al.
The American Journal of Pathology|April 12, 2002
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phaseRoberto Chiarle, Yan Fan, Roberto Piva, et al.
British Journal of Haematology|November 29, 2011
Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single arrayIvo Kwee, Andrea Rinaldi, Paola Rancoita, et al.
Blood|November 9, 2002
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumorsRoberto Chiarle, Jerald Z Gong, Ilaria Guasparri, et al.
Advances in Hematology|February 19, 2011
Pathobiology of anaplastic large cell lymphomaPier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, et al.
Journal of Molecular Endocrinology|April 20, 2011
Anaplastic lymphoma kinase in human cancerAntonella Barreca, Elena Lasorsa, Ludovica Riera, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2005
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activationWu Peng, Xin Zhang, Nehal Mohamed, et al.
Pageof 24

Showing results (61-70 of 239) with videos related to

Sort By:
Pageof 24
Cancer Research|January 30, 2019
The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3Giovanni Gambi, Elisabetta Di Simone, Veronica Basso, et al.
Blood|September 29, 2005
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomasRoberto Piva, Roberto Chiarle, Andrea D Manazza, et al.
Virchows Archiv : an International Journal of Pathology|July 10, 2003
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumoursMarco Chilosi, Alberto Zamò, Antonietta Brighenti, et al.
Anticancer Research|December 27, 2011
Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinomaDeepu Mirchandani, Daniel F Roses, Giorgio Inghirami, et al.
The American Journal of Pathology|April 12, 2002
S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phaseRoberto Chiarle, Yan Fan, Roberto Piva, et al.
British Journal of Haematology|November 29, 2011
Integrated DNA copy number and methylation profiling of lymphoid neoplasms using a single arrayIvo Kwee, Andrea Rinaldi, Paola Rancoita, et al.
Blood|November 9, 2002
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumorsRoberto Chiarle, Jerald Z Gong, Ilaria Guasparri, et al.
Advances in Hematology|February 19, 2011
Pathobiology of anaplastic large cell lymphomaPier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, et al.
Journal of Molecular Endocrinology|April 20, 2011
Anaplastic lymphoma kinase in human cancerAntonella Barreca, Elena Lasorsa, Ludovica Riera, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2005
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activationWu Peng, Xin Zhang, Nehal Mohamed, et al.
Pageof 24